Largest Biotechnology Companies By Total Asset

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Total Asset
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Total AssetEfficiencyMarket RiskExp Return
1ALDX Aldeyra
104.61 T
 0.12 
 4.75 
 0.58 
2OTLK OUTLOOK THERAPEUTICS INC
28.82 T
(0.10)
 4.69 
(0.45)
3MLTX MoonLake Immunotherapeutics
477.93 B
(0.15)
 2.84 
(0.43)
4ZYME Zymeworks Common Stock
463.09 B
(0.06)
 3.30 
(0.21)
5ABBV AbbVie Inc
135.16 B
 0.20 
 1.39 
 0.28 
6INO Inovio Pharmaceuticals
113.2 B
 0.01 
 4.72 
 0.06 
7AMGN Amgen Inc
91.84 B
 0.20 
 1.50 
 0.30 
8GILD Gilead Sciences
58.99 B
 0.22 
 1.56 
 0.34 
9IMRX Immuneering Corp
52.71 B
(0.12)
 3.80 
(0.44)
10GMAB Genmab AS
45.81 B
(0.01)
 2.80 
(0.04)
11COYA Coya Therapeutics, Common
44.35 B
 0.09 
 4.03 
 0.36 
12REGN Regeneron Pharmaceuticals
37.76 B
(0.07)
 2.06 
(0.14)
13NERV Minerva Neurosciences
37.14 B
(0.07)
 4.09 
(0.30)
14HLN Haleon plc
34.31 B
 0.09 
 1.43 
 0.13 
15BIIB Biogen Inc
28.05 B
(0.06)
 1.76 
(0.11)
16VRTX Vertex Pharmaceuticals
22.53 B
 0.24 
 1.50 
 0.36 
17BNTX BioNTech SE
22.53 B
(0.07)
 3.26 
(0.23)
18GRFS Grifols SA ADR
21.44 B
 0.01 
 2.73 
 0.02 
19KTTAW Pasithea Therapeutics Corp
16.06 B
 0.07 
 20.28 
 1.40 
20KTTA Pasithea Therapeutics Corp
16.06 B
(0.14)
 7.65 
(1.05)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value. Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY